The Three-Legged Stool That Cannot Stand: How Prevnar 20 Exemplifies the Childhood Vaccine Fraud

On Childhood Vaccination - The NSE Framework - Plus Questions for Your Doctor

When examining whether any medical intervention is justified, particularly for children, there's a simple yet powerful framework that cuts through the noise: the three-legged stool of Necessity, Safety, and Effectiveness. Like any three-legged stool, if even one leg collapses, the entire structure falls. This framework, developed by me in 2022 as a way to think clearly about childhood vaccination, reveals an uncomfortable truth - not a single routine childhood vaccine can withstand this basic scrutiny. The latest addition to this rogues' gallery, that I’ve recently become aware of, is Prevnar [Prevnar 20 to be precise,] a pneumococcal vaccine that exemplifies the fraudulent template used to push unnecessary, unsafe, and ineffective products onto our most vulnerable population.

Prevnar 20, manufactured by Pfizer and targeting 20 strains of Streptococcus pneumoniae, recently caught attention through Candace Owens' groundbreaking "A Shot in the Dark" series. What makes this vaccine particularly insidious is how perfectly it demonstrates the systematic deception at the heart of the childhood vaccination program. The FDA's own documentation reveals that most pneumococcal infections are mild, yet parents are terrorized with rare worst-case scenarios to manufacture consent for injecting their babies at 2, 4, 6, and 12-15 months with a cocktail containing aluminum phosphate, polysorbate 80, and modified diphtheria toxin. The package insert admits there's no established antibody level that predicts protection, and for seven of the twenty strains, approval was based solely on antibody production - not disease prevention. This is the same playbook used for every childhood vaccine: exaggerate the threat, hide the true risks, and redefine effectiveness to mean "produces antibodies" rather than "prevents disease."

The clinical trial fraud runs even deeper, as exposed in Aaron Siri's devastating exchange with Dr. Paul Offit, considered the world's leading vaccine safety expert. When Siri pointed out that not a single routine childhood vaccine was licensed based on a true placebo-controlled trial, Dr. Paul Offit's response revealed the corruption at the core of vaccine science. Instead of saline placebos, these trials use other vaccines or toxic aluminum adjuvants as "controls," then declare the new vaccine safe because it causes no more harm than the equally untested comparator. This "vaccine safety pyramid scheme," as Siri calls it, just claimed another victim: in June 2025, the FDA approved MenQuadfi for infants as young as 6 weeks old, despite 5.3% experiencing serious adverse events in trials. How was this deemed acceptable? Because it was compared to Menveo (3.6% serious events), which was compared to Menactra, which was compared to Menomune - none ever tested against a true placebo. In Prevnar's case, the same shell game showed serious adverse events in 8.2% of recipients - including death, life-threatening conditions, and permanent disability - yet this was deemed acceptable because the control vaccine showed similar devastation. As Siri notes, this is "morally and ethically bankrupt," especially when pharmaceutical companies' paid researchers decide which deaths and injuries to count as vaccine-related. The entire safety assessment is theater, designed to create the illusion of scientific rigor while protecting the program rather than children.

There's a sinister logic to the timing of these injections that becomes clear once you understand the stakes. The entire childhood vaccine schedule is front-loaded into the first 12-18 months of life, with most doses administered before children can speak. This isn't coincidence - it's strategy. When a verbal three-year-old suddenly loses language, stops making eye contact, or develops seizures after vaccination, the connection is undeniable. But when the same regression happens to a pre-verbal infant, doctors can gaslight parents with "born that way" or "would have happened anyway." The case of baby Sawyer in Maine reveals how deadly this system can be: at just 8 weeks old, still fighting an illness, he received four vaccines including Prevnar 13. Within 34 hours, he was dead. The medical examiner blamed the parents for "inappropriate sleep position" - until independent testing revealed aluminum levels at adult toxicity in his blood. His mother, a registered nurse who had asked to delay the vaccines because her baby was sick, was told by the pediatrician it would be "perfectly safe." The medical establishment has weaponized the natural parental instinct to protect by creating a system where the evidence of harm is systematically obscured. They've turned the most vulnerable period of child development into a window of plausible deniability, ensuring that by the time parents might connect the dots, their children have already received dozens of shots and any damage can be attributed to genetics, bad luck, or anything but the injections.

The segregation of unvaccinated children from daycare settings reveals another layer of this protection racket - but it's not about protecting children from disease. Unvaccinated children stand out like sore thumbs in any group setting: they develop faster, rarely get sick, and when they are ill, they recover quickly without complications. These children are walking control groups that threaten the entire narrative. If vaccinated and unvaccinated children mixed freely in early childhood settings, mothers would immediately notice the stark differences in health, development, and vitality. The ban on unvaccinated children in daycare isn't about public health - it's about preventing parents from discovering what baseline human health actually looks like. As the data from doctors like Paul Thomas demonstrates, unvaccinated children have dramatically lower rates of ear infections, allergies, ADHD, autism, and virtually every chronic condition plaguing modern childhood.

Prevnar 20 represents the perfection of a fraud template that has been refined over decades: manufacture fear about mild diseases, use rigged trials with no true placebos, redefine effectiveness to mean antibody production rather than disease prevention, hide safety signals behind statistical manipulation, and mandate the product before children can speak to obscure the damage. The three-legged stool analysis reveals that not a single leg can support this vaccine - necessity fails because pneumococcal disease is predominantly mild and self-limiting, safety collapses under the weight of untested carcinogenicity and 8.2% serious adverse events, and effectiveness crumbles when antibody levels don't correlate with protection. This isn't failed science; it's successful racketeering. They will continue using this template, poisoning generation after generation, extracting billions while leaving a wake of damaged children, until they are stopped. The question isn't whether the stool has fallen - it's whether we'll finally clear away the wreckage and protect our children from those who profit from their harm.

Package+insert+ +prevnar+20

489KB ∙ PDF file

Download

Download

Systematic Analysis of Prevnar 20 Using the NSE Framework

Executive Summary

Prevnar 20 is a pneumococcal 20-valent conjugate vaccine manufactured by Pfizer, targeting 20 strains of Streptococcus pneumoniae. This analysis examines whether the vaccine meets the three critical criteria of Necessity, Safety, and Effectiveness using the framework provided.

Key Finding: All three legs of the stool show significant weaknesses, with particular concerns in the safety and effectiveness domains.

---

I. NECESSITY ANALYSIS

Disease Burden Investigation

1. Pre-vaccine Disease Statistics

The package insert notably lacks comprehensive pre-vaccine disease incidence data. This omission is significant because:

• No baseline mortality rates are provided for the 20 targeted serotypes

• No age-stratified disease burden data before vaccine introduction

• No comparison to historical declining trends

2. Risk Exaggeration Analysis

Red Flags Identified:

• The insert uses broad language about "pneumonia and invasive disease" without quantifying actual risk

• No stratification of risk by health status (healthy vs. immunocompromised)

• Conflates all pneumococcal disease without distinguishing mild from severe presentations

• No mention of the fact that most people exposed to S. pneumoniae remain asymptomatic carriers

3. Natural Immunity Assessment

Critical Omission: The package insert completely ignores natural immunity:

• No discussion of naturally acquired immunity through exposure

• No comparison of vaccine-induced vs. natural immunity duration

• No mention that historically, most people developed natural immunity without serious consequences

Necessity Verdict: BROKEN

The necessity leg fails due to lack of transparent disease burden data and complete omission of natural immunity considerations.

---

II. EFFECTIVENESS ANALYSIS

Core Effectiveness Questions

1. Primary Endpoint Manipulation

Major Red Flag: The vaccine approval relies heavily on surrogate endpoints:

• Effectiveness is measured by antibody levels (OPA titers), not clinical disease prevention

• Quote from insert: "An opsonic antibody titer that is predictive of protection against invasive pneumococcal disease or pneumococcal pneumonia has not been established"

• For 7 serotypes (8, 10A, 11A, 12F, 15B, 22F, 33F), approval is based ONLY on antibody response under "accelerated approval"

2. Strain Replacement/Mutation

Not Addressed: The insert provides no data on:

• Whether targeting 20 serotypes leads to replacement with non-vaccine serotypes

• Long-term epidemiological impact

• Total disease burden changes

3. Duration and Quality

Significant Concerns:

• No long-term effectiveness data provided

• Study follow-up was only 6 months for safety

• No data on duration of any protection

• No booster schedule established, suggesting waning immunity expected

4. Real-world Failure Documentation

Limited Data:

• The Prevnar 13 efficacy study (CAPiTA) showed only 45.6% efficacy against vaccine-type pneumonia

• No real-world effectiveness data for the 7 additional serotypes

• No data on breakthrough infections in vaccinated populations

Effectiveness Verdict: BROKEN

The effectiveness leg fails due to reliance on surrogate endpoints with no established protective threshold and lack of real-world disease prevention data.

---

III. SAFETY ANALYSIS

A. Clinical Trial Fraud Detection

1. Control Group Manipulation

MAJOR SCIENTIFIC FRAUD IDENTIFIED:

• No true placebo (saline-only) control group used in primary comparisons

• Adults ≥60 received either Prevnar 20 vs. Prevnar 13/PPSV23 combination

• This means adverse events were compared between vaccines, not against true baseline

• This design systematically hides the true adverse event rate

2. Observation Period Truncation

Inadequate Monitoring:

• Local reactions: 10 days

• Systemic reactions: 7 days

• Serious adverse events: 6 months

• No long-term safety follow-up beyond 6 months

• Autoimmune conditions, cancer, and other delayed effects impossible to detect

B. Ingredient Toxicology Analysis

1. Aluminum Compounds

• Contains 125 μg aluminum as aluminum phosphate adjuvant

• No discussion of aluminum accumulation with repeated vaccines

• No mention of aluminum's neurotoxic properties

• No consideration of blood-brain barrier penetration

2. Polysorbate 80

• Contains 100 μg polysorbate 80

• Known to disrupt blood-brain barrier

• No discussion of reproductive toxicity

• No analysis of synergistic effects with aluminum

3. Formaldehyde

• Not listed in ingredients but likely used in manufacturing

• Carcinogenic properties not discussed

4. Foreign DNA/Proteins

• Contains 51 μg CRM197 (modified diphtheria toxin)

• Potential for autoimmune reactions not studied

• Long-term effects of injecting bacterial proteins unknown

C. Undisclosed/Untested Risks

CRITICAL ADMISSION (Section 13.1):

"Prevnar 20 has not been evaluated for the potential to cause carcinogenicity, genotoxicity, or impairment of male fertility"

This means:

• Cancer-causing potential: NOT TESTED

• DNA damage potential: NOT TESTED

• Male fertility effects: NOT TESTED

• Female fertility: Only limited rabbit study

D. Declared Side Effects Analysis

Paradoxical Finding: Common side effects mimic the disease supposedly being prevented:

• Fever (systemic inflammation like pneumonia)

• Fatigue and muscle pain (flu-like symptoms)

• In 60+ age group: >50% experienced injection site pain

• Systemic reactions in >50% of recipients

Safety Verdict: SEVERELY BROKEN

The safety leg is demolished by failure to use true placebos, untested carcinogenicity/genotoxicity, and toxic ingredients with no long-term safety data.

---

IV. LOGICAL FALLACY DETECTION

Circular Reasoning Examples

1. "Antibodies equal protection": Assumes OPA titers prevent disease without established threshold

2. "Benefits outweigh risks": Risks not properly studied (no cancer/fertility testing)

3. "Safe because approved": Approval based on flawed studies

Definition Manipulation

• "Effective": Redefined from "prevents disease" to "produces antibodies"

• "Immunogenicity": Used as proxy for real-world protection

• "Noninferior": Used to avoid showing actual benefit

Statistical Manipulation

• Relative risk reduction emphasized over absolute risk

• No number needed to vaccinate (NNV) provided

• Comparison to other vaccines rather than true placebo

---

V. SYSTEMIC CORRUPTION ANALYSIS

1. Regulatory Capture Evidence

• Accelerated approval for 7 serotypes based only on antibody levels

• FDA accepted surrogate endpoints without disease prevention proof

• Fast-track approval despite incomplete safety testing

2. Financial Conflicts

• All studies funded by Pfizer

• No independent verification of results

• Researchers likely had financial ties to manufacturer

3. Liability Protection

• Vaccine manufacturers have liability immunity under 1986 Act

• Burden of proof on injured parties through VICP

• Removes market incentive for safety

---

VI. INFORMED CONSENT VIOLATIONS

True informed consent is impossible because:

1. Ingredients not fully disclosed: Manufacturing residuals not listed

2. Risks minimized: No mention of untested cancer/fertility risks

3. Benefits exaggerated: Antibody levels presented as disease prevention

4. Critical omissions:

   • No discussion of natural immunity option

   • No mention of serotype replacement risk

   • No long-term safety data exists

---

FINAL SYNTHESIS

1. Which Legs Are Broken?

ALL THREE LEGS ARE BROKEN:

• Necessity: No clear disease burden data, natural immunity ignored

• Safety: Fraudulent trial design, untested for cancer/fertility, toxic ingredients

• Effectiveness: Based on surrogate markers, not disease prevention

2. Grand Deception Scale: 8/10

• Hidden data: True placebo results hidden

• Manipulated definitions: "Effectiveness" = antibodies, not disease prevention

• Exaggerated benefits: Assumes antibodies prevent disease without proof

• Minimized risks: Cancer, fertility, autoimmunity not studied

• Coercive implementation: Pushed through healthcare recommendations

3. Risk-Benefit Reality

TRUE Risk of Disease:

• Not quantified in package insert

• Most exposed individuals remain healthy

• Natural immunity provides robust protection

TRUE Risk of Vaccine:

• Immediate: >50% adverse events

• Long-term: Completely unknown (cancer, fertility, autoimmunity not studied)

• Cumulative: 20 antigens + toxic adjuvants + repeated doses

Informed Consent: Impossible with current information gaps

---

Conclusion

Prevnar 20 exemplifies modern vaccine development's systematic problems: surrogate endpoints replacing clinical outcomes, fraudulent safety testing using vaccine-vs-vaccine comparisons, complete absence of critical safety studies, and regulatory capture allowing approval based on antibody levels alone. The three-legged stool cannot stand when all three legs show critical fractures.

Questions Parents Should Ask Their Doctor About Prevnar:

About Necessity:

1. "What is the actual risk of my healthy child dying from pneumococcal disease if unvaccinated? Please provide specific numbers, not general statements."

2. "Can you show me data on how many children developed natural immunity to pneumococcus before this vaccine existed?"

3. "Since the CDC admits most pneumococcal infections are mild, why does my baby need 4 doses before 15 months?"

About Safety:

1. "Why wasn't Prevnar 20 tested against a saline placebo instead of another vaccine?"

2. "The package insert shows 8.2% of children had serious adverse events in trials. How is that considered safe?"

3. "Why does the insert state this vaccine was never tested for cancer-causing potential or effects on fertility?"

4. "What exactly is in this vaccine besides the antigens? Please explain what aluminum phosphate and polysorbate 80 do in my baby's body."

About Effectiveness:

1. "The package insert admits there's no established antibody level that predicts protection. So how do you know this vaccine actually prevents disease?"

2. "Why was approval for 7 of the 20 strains based only on antibody production, not disease prevention?"

3. "If vaccinated children can still get and spread pneumococcal disease, what's the actual benefit?"

Critical Follow-ups:

1. "Can you provide me with studies comparing overall health outcomes between children who received Prevnar and those who didn't?"

2. "If my child has a serious reaction after this vaccine, will you report it to VAERS and support our family?"

3. "Given that the manufacturer has zero liability for injuries, who is responsible if my child is harmed?"

The Most Important Question: "Doctor, have you personally read the entire Prevnar 20 package insert, including section 13.1 about untested risks, and can you explain why you're comfortable recommending a product with this safety profile for my healthy infant?"

I appreciate you being here.

If you've found the content interesting, useful and maybe even helpful, please consider supporting it through a small paid subscription. While 99% of everything here is free, your paid subscription is important as it helps in covering some of the operational costs and supports the continuation of this independent research and journalism work. It also helps keep it free for those that cannot afford to pay.

Please make full use of the Free Libraries.

Unbekoming Interview Library: Great interviews across a spectrum of important topics.

Unbekoming Book Summary Library: Concise summaries of important books.

Stories

I'm always in search of good stories, people with valuable expertise and helpful books. Please don't hesitate to get in touch at unbekoming@outlook.com

Baseline Human Health

Watch and share this profound 21-minute video to understand and appreciate what health looks like without vaccination.